No Evidence for Drug-Specific Activation of Circulating T Cells from Patients with HLA-DRB1*07:01-Restricted Lapatinib-Induced Liver Injury. (2016)

First Author: Faulkner L
Attributed to:  Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acs.chemrestox.6b00400

PubMed Identifier: 27989141

Publication URI: http://europepmc.org/abstract/MED/27989141

Type: Journal Article/Review

Volume: 29

Parent Publication: Chemical research in toxicology

Issue: 12

ISSN: 0893-228X